首页 > 最新文献

Die Anaesthesiologie最新文献

英文 中文
[Update 2025 of the S3 guidelines: "Sepsis-Prevention, diagnosis, treatment and follow-up care" : What is new?] [S3指南2025年更新:“败血症——预防、诊断、治疗和随访护理”:有什么新内容?]]
IF 1 Pub Date : 2025-12-01 Epub Date: 2025-10-30 DOI: 10.1007/s00101-025-01609-3
Caroline Neumann, Daniel Ebert, Michael Bucher, Michael Bauer

The update of the S3 guidelines "Sepsis-Prevention, diagnosis, treatment and follow-up care" was published on 25 July 2025. The new guidelines address 29 new and 16 revised recommendations, with 43 recommendations remaining unchanged from the previous version. The 2025 update is a targeted adaptation of the internationally recognized recommendations of the Surviving Sepsis Campaign from 2021. The focus is on early individualized and evidence-based treatment, the integration of structured follow-up care after hospital discharge and a stronger focus on patient-centered comprehensive care beyond acute treatment. Despite advances in early detection, antibiotic treatment and intensive medical care of patients, sepsis and septic shock remain potentially life-threatening conditions, underlining the necessity for early diagnosis and the initiation of appropriate treatment.

S3指南“败血症——预防、诊断、治疗和随访护理”的更新于2025年7月25日发布。新指南涉及29项新建议和16项修订建议,其中43项建议与前一版本相比保持不变。2025年的更新是对国际公认的败血症生存运动2021年建议的有针对性的调整。重点是早期个体化和循证治疗,出院后结构化随访护理的整合,以及在急性治疗之外更加注重以患者为中心的综合护理。尽管在早期发现、抗生素治疗和患者重症监护方面取得了进展,但败血症和感染性休克仍然是可能危及生命的疾病,因此必须及早诊断并开始适当治疗。
{"title":"[Update 2025 of the S3 guidelines: \"Sepsis-Prevention, diagnosis, treatment and follow-up care\" : What is new?]","authors":"Caroline Neumann, Daniel Ebert, Michael Bucher, Michael Bauer","doi":"10.1007/s00101-025-01609-3","DOIUrl":"10.1007/s00101-025-01609-3","url":null,"abstract":"<p><p>The update of the S3 guidelines \"Sepsis-Prevention, diagnosis, treatment and follow-up care\" was published on 25 July 2025. The new guidelines address 29 new and 16 revised recommendations, with 43 recommendations remaining unchanged from the previous version. The 2025 update is a targeted adaptation of the internationally recognized recommendations of the Surviving Sepsis Campaign from 2021. The focus is on early individualized and evidence-based treatment, the integration of structured follow-up care after hospital discharge and a stronger focus on patient-centered comprehensive care beyond acute treatment. Despite advances in early detection, antibiotic treatment and intensive medical care of patients, sepsis and septic shock remain potentially life-threatening conditions, underlining the necessity for early diagnosis and the initiation of appropriate treatment.</p>","PeriodicalId":72805,"journal":{"name":"Die Anaesthesiologie","volume":" ","pages":"827-838"},"PeriodicalIF":1.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145410862","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Breaking with tradition: perioperative care without fasting or medication changes for diabetic foot surgery. 打破传统:糖尿病足手术的围手术期护理,无需禁食或药物改变。
IF 1 Pub Date : 2025-12-01 Epub Date: 2025-10-06 DOI: 10.1007/s00101-025-01598-3
Ahmet Murat Gül, Gülsen Keskin, Aslı Dönmez, Serkan Solak, İbrahim Yılmaz, Hikmet Erhan Güven

Background: This study explores a new approach for managing high-risk diabetic patients undergoing diabetic-foot surgery, where traditional practices like preoperative fasting and medication changes are bypassed. We aimed to assess the safety and complications of using a popliteal-sciatic nerve block in this unique scenario, while also evaluating the impact on blood glucose levels and surgeon satisfaction.

Methods: The study included high-risk patients classified in the American Society of Anesthesiologists (ASA) III group, where general anesthesia was avoided due to elevated risk factors. Crucially, patients maintained their regular daily routines, with no changes to their medication regimen and they were not required to fast. After enjoying a light breakfast, patients were prepped with standard monitoring and an ultrasound-guided popliteal-sciatic block was performed with the patient in the prone position. Data on patient outcomes and surgeon satisfaction were recorded and analyzed.

Results: A total of 320 blocks were performed as some of the 142 patients required multiple surgical interventions. All of these patients successfully underwent surgery without the need for general anesthesia. Surgeon satisfaction was remarkable high, with a mean score of 4.6 ± 0.8 on a 5-point Likert scale (1 = very poor, 5 = very good), and only 1 patient (0.3%) developed a postoperative hematoma. Patients who did not require sedatives (midazolam) and additional analgesics (fentanyl) had higher surgeon satisfaction scores.

Conclusion: Our findings reveal that for high-risk patients with chronic conditions, a popliteal-sciatic nerve block offers a safe and effective alternative for diabetic foot surgery, eliminating the need for fasting or medication adjustments. This method not only ensures patient safety but also potentially setting a new standard in perioperative care.

背景:本研究探索了一种管理高危糖尿病足手术患者的新方法,该方法绕过了术前禁食和药物改变等传统做法。我们的目的是评估在这种特殊情况下使用腘-坐骨神经阻滞的安全性和并发症,同时评估对血糖水平和外科医生满意度的影响。方法:研究纳入美国麻醉学会(ASA) III组的高危患者,该组患者因危险因素升高而避免全身麻醉。至关重要的是,患者保持了正常的日常生活,没有改变他们的药物治疗方案,也不需要禁食。在享用清淡的早餐后,对患者进行标准监测,并在患者俯卧位下进行超声引导腘-坐骨阻滞。记录和分析患者预后和外科医生满意度的数据。结果:142例患者中部分患者需要多次手术干预,共进行了320例阻滞。所有患者均成功接受手术,无需全身麻醉。外科医生的满意度非常高,5分Likert量表的平均得分为4.6 ±0.8分(1 =非常差,5 =非常好),只有1名患者(0.3%)发生术后血肿。不需要镇静剂(咪达唑仑)和额外止痛药(芬太尼)的患者有更高的外科医生满意度评分。结论:我们的研究结果表明,对于患有慢性疾病的高危患者,腘-坐骨神经阻滞为糖尿病足手术提供了一种安全有效的替代方案,无需禁食或调整药物。这种方法不仅保证了患者的安全,而且有可能为围手术期护理树立新的标准。
{"title":"Breaking with tradition: perioperative care without fasting or medication changes for diabetic foot surgery.","authors":"Ahmet Murat Gül, Gülsen Keskin, Aslı Dönmez, Serkan Solak, İbrahim Yılmaz, Hikmet Erhan Güven","doi":"10.1007/s00101-025-01598-3","DOIUrl":"10.1007/s00101-025-01598-3","url":null,"abstract":"<p><strong>Background: </strong>This study explores a new approach for managing high-risk diabetic patients undergoing diabetic-foot surgery, where traditional practices like preoperative fasting and medication changes are bypassed. We aimed to assess the safety and complications of using a popliteal-sciatic nerve block in this unique scenario, while also evaluating the impact on blood glucose levels and surgeon satisfaction.</p><p><strong>Methods: </strong>The study included high-risk patients classified in the American Society of Anesthesiologists (ASA) III group, where general anesthesia was avoided due to elevated risk factors. Crucially, patients maintained their regular daily routines, with no changes to their medication regimen and they were not required to fast. After enjoying a light breakfast, patients were prepped with standard monitoring and an ultrasound-guided popliteal-sciatic block was performed with the patient in the prone position. Data on patient outcomes and surgeon satisfaction were recorded and analyzed.</p><p><strong>Results: </strong>A total of 320 blocks were performed as some of the 142 patients required multiple surgical interventions. All of these patients successfully underwent surgery without the need for general anesthesia. Surgeon satisfaction was remarkable high, with a mean score of 4.6 ± 0.8 on a 5-point Likert scale (1 = very poor, 5 = very good), and only 1 patient (0.3%) developed a postoperative hematoma. Patients who did not require sedatives (midazolam) and additional analgesics (fentanyl) had higher surgeon satisfaction scores.</p><p><strong>Conclusion: </strong>Our findings reveal that for high-risk patients with chronic conditions, a popliteal-sciatic nerve block offers a safe and effective alternative for diabetic foot surgery, eliminating the need for fasting or medication adjustments. This method not only ensures patient safety but also potentially setting a new standard in perioperative care.</p>","PeriodicalId":72805,"journal":{"name":"Die Anaesthesiologie","volume":" ","pages":"811-817"},"PeriodicalIF":1.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145234449","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A clotting time longer than 226 s in the INTEM channel of the thromboelastometer is an independent risk factor for mortality during bleeding. 凝血时间超过226 s在血栓弹性计的INTEM通道是出血期间死亡的独立危险因素。
IF 1 Pub Date : 2025-12-01 Epub Date: 2025-11-10 DOI: 10.1007/s00101-025-01602-w
Hagen Bomberg, Klaus Görlinger, Stefan Wagenpfeil, Thomas Volk, Sven Oliver Schneider

Background and objective: During bleeding the prolongation of the clotting time (CTINTEM) measured by rotational thromboelastometry (ROTEM) can detect alterations in the intrinsic pathway; however, the significance of a prolonged CTINTEM for risk stratification in patients with bleeding and the treatment with fresh frozen plasma remains unclear.

Material and methods: A total of 2197 consecutive patients between 2014 and 2020 were retrospectively investigated. All patients were tested by ROTEM during bleeding at the Saarland University Hospital. The CTINTEM values were compared to mortality at 30 days. Discrimination was assessed with C statistic. Adjusted hazard ratios (adjHR, 95% confidence interval, CI) were calculated with multivariable Cox models.

Results: The results of the C‑statistic showed that CTINTEM (C statistic 0.62, optimal threshold > 226 s) had a predictive power for 30-day mortality. The determined threshold value of CTINTEM > 226 s remained an independent risk predictor for 30-day mortality even after adjustment for confounding factors (adjHR 2.6, 95% CI 2.1-3.2, p < 0.001). The 30-day mortality rate was significantly increased in the group with CTINTEM > 226 s (29% versus 15%, p < 0.001). A multivariable analysis showed that treatment with fresh frozen plasma was not associated with increased 30-day mortality in patients with CTINTEM > 226 s, in contrast to all patients.

Conclusion: Our results indicate that CTINTEM > 226s detected alterations in the intrinsic pathway might be an independent predictor for 30-day mortality in patients with bleeding and could be useful for decision making regarding treatment with fresh frozen plasma.

背景和目的:在出血过程中,旋转血栓弹性测量仪(ROTEM)测量的凝血时间(cttem)的延长可以检测内在通路的改变;然而,延长CTINTEM对出血患者风险分层和新鲜冷冻血浆治疗的意义尚不清楚。材料与方法:回顾性调查2014 - 2020年连续2197例患者。所有患者均在萨尔大学医院出血期间进行ROTEM检测。将CTINTEM值与30天死亡率进行比较。用C统计量评价歧视程度。采用多变量Cox模型计算校正风险比(adjHR, 95%置信区间,CI)。结果:C统计量结果显示,cttem (C统计量0.62,最佳阈值> 226 s)对30天死亡率具有预测能力。即使校正了混杂因素,确定的阈值CTINTEM > 226 s仍然是30天死亡率的独立风险预测因子(adjHR 2.6, 95% CI 2.1-3.2, p INTEM > 226 s)(29%对15%,p INTEM > 226 s,与所有患者相比。结论:我们的研究结果表明,CTINTEM > 226检测到的内在通路的改变可能是出血患者30天死亡率的独立预测因子,并可能对新鲜冷冻血浆治疗的决策有用。
{"title":"A clotting time longer than 226 s in the INTEM channel of the thromboelastometer is an independent risk factor for mortality during bleeding.","authors":"Hagen Bomberg, Klaus Görlinger, Stefan Wagenpfeil, Thomas Volk, Sven Oliver Schneider","doi":"10.1007/s00101-025-01602-w","DOIUrl":"10.1007/s00101-025-01602-w","url":null,"abstract":"<p><strong>Background and objective: </strong>During bleeding the prolongation of the clotting time (CT<sub>INTEM</sub>) measured by rotational thromboelastometry (ROTEM) can detect alterations in the intrinsic pathway; however, the significance of a prolonged CT<sub>INTEM</sub> for risk stratification in patients with bleeding and the treatment with fresh frozen plasma remains unclear.</p><p><strong>Material and methods: </strong>A total of 2197 consecutive patients between 2014 and 2020 were retrospectively investigated. All patients were tested by ROTEM during bleeding at the Saarland University Hospital. The CT<sub>INTEM</sub> values were compared to mortality at 30 days. Discrimination was assessed with C statistic. Adjusted hazard ratios (adjHR, 95% confidence interval, CI) were calculated with multivariable Cox models.</p><p><strong>Results: </strong>The results of the C‑statistic showed that CT<sub>INTEM</sub> (C statistic 0.62, optimal threshold > 226 s) had a predictive power for 30-day mortality. The determined threshold value of CT<sub>INTEM</sub> > 226 s remained an independent risk predictor for 30-day mortality even after adjustment for confounding factors (adjHR 2.6, 95% CI 2.1-3.2, p < 0.001). The 30-day mortality rate was significantly increased in the group with CT<sub>INTEM</sub> > 226 s (29% versus 15%, p < 0.001). A multivariable analysis showed that treatment with fresh frozen plasma was not associated with increased 30-day mortality in patients with CT<sub>INTEM</sub> > 226 s, in contrast to all patients.</p><p><strong>Conclusion: </strong>Our results indicate that CT<sub>INTEM</sub> > 226s detected alterations in the intrinsic pathway might be an independent predictor for 30-day mortality in patients with bleeding and could be useful for decision making regarding treatment with fresh frozen plasma.</p>","PeriodicalId":72805,"journal":{"name":"Die Anaesthesiologie","volume":" ","pages":"818-826"},"PeriodicalIF":1.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12660322/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145483932","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Culture as a success factor: why organizational and team culture in high-risk areas of medicine deserve more attention]. [文化作为成功因素:为什么高风险医学领域的组织和团队文化值得更多关注]。
IF 1 Pub Date : 2025-12-01 Epub Date: 2025-11-06 DOI: 10.1007/s00101-025-01605-7
Johannes Bresser

Background: In high-risk areas of medicine, such as anesthesiology, intensive care, emergency medicine and pain management, existing organizational and team cultures can significantly impede the delivery of effective and safe care. A predominantly numbers-driven management approach, structural overload and sometimes insufficient leadership competency contribute to overburdening, demotivation and the departure of key personnel. This in turn exacerbates the already critical shortage of healthcare professionals.

Aim of the study: This study explores the extent to which a targeted transformation toward a Just Culture, a culture of fairness and trust, can enhance patient safety, improve staff well-being and sustainably support the performance and economic resilience of medical organizations.

Material and methods: The study is based on a narrative review of the current literature on the topic of Just Culture, leadership, error and learning culture and team development. In addition, selected practical examples from the German and international healthcare sectors were analyzed. The review also incorporated studies on the effectiveness of (simulation) training and incident reporting and learning systems.

Results: The introduction of a Just Culture promotes a climate of trust, fairness and continuous learning in the workplace. It facilitates open communication about adverse events, supports systematic root cause analysis and reduces individual blame. Staff report increased psychological safety, reduced work-related stress and higher job satisfaction. Modern leadership approaches, such as transformational, shared and humble leadership, can further enhance teamwork and care quality. Evidence also suggests positive effects on employee retention and organizational performance, although causal relationships remain underexplored.

Discussion: An organizational culture shaped by Just Culture principles constitutes a key success factor for healthcare institutions. It fosters psychological safety, strengthens a sense of responsibility and enables collective learning; however, successful implementation requires a targeted evolution of leadership structures, continuous training and the development of supportive frameworks, such as reporting systems and interprofessional reflection formats. When effectively implemented, Just Culture can help secure care quality, retain skilled professionals and create a strategic advantage in an increasingly complex and economically pressured healthcare environment.

背景:在高风险医学领域,如麻醉学、重症监护、急诊医学和疼痛管理,现有的组织和团队文化可能严重阻碍提供有效和安全的护理。主要以数字为导向的管理方法、结构上的超负荷以及有时领导能力的不足,都导致了负担过重、缺乏动力和关键人员的离职。这反过来又加剧了医疗保健专业人员的严重短缺。研究目的:本研究探讨了有针对性地向公正文化(一种公平和信任的文化)转变,在多大程度上可以增强患者安全,改善员工福祉,并可持续地支持医疗机构的绩效和经济弹性。材料和方法:这项研究是基于对当前关于公正文化、领导、错误和学习文化以及团队发展主题的文献的叙述回顾。此外,还分析了德国和国际医疗保健部门的实际案例。检讨亦包括对(模拟)训练和事故报告及学习系统的成效的研究。结果:公正文化的引入促进了工作场所信任、公平和持续学习的氛围。它促进了不良事件的公开沟通,支持系统的根本原因分析,减少了个人责任。员工报告心理安全感增加,工作压力减少,工作满意度提高。现代领导方法,如变革型领导、共享型领导和谦逊型领导,可以进一步提高团队合作和关怀质量。证据还表明,员工保留和组织绩效有积极影响,尽管因果关系仍未得到充分探讨。讨论:由公正文化原则塑造的组织文化是医疗机构成功的关键因素。培养心理安全感,增强责任感,促进集体学习;但是,成功的执行需要有针对性地发展领导结构、持续培训和发展支助框架,例如报告制度和专业间反思格式。如果得到有效实施,Just Culture可以帮助确保护理质量,留住熟练的专业人员,并在日益复杂和经济压力的医疗保健环境中创造战略优势。
{"title":"[Culture as a success factor: why organizational and team culture in high-risk areas of medicine deserve more attention].","authors":"Johannes Bresser","doi":"10.1007/s00101-025-01605-7","DOIUrl":"10.1007/s00101-025-01605-7","url":null,"abstract":"<p><strong>Background: </strong>In high-risk areas of medicine, such as anesthesiology, intensive care, emergency medicine and pain management, existing organizational and team cultures can significantly impede the delivery of effective and safe care. A predominantly numbers-driven management approach, structural overload and sometimes insufficient leadership competency contribute to overburdening, demotivation and the departure of key personnel. This in turn exacerbates the already critical shortage of healthcare professionals.</p><p><strong>Aim of the study: </strong>This study explores the extent to which a targeted transformation toward a Just Culture, a culture of fairness and trust, can enhance patient safety, improve staff well-being and sustainably support the performance and economic resilience of medical organizations.</p><p><strong>Material and methods: </strong>The study is based on a narrative review of the current literature on the topic of Just Culture, leadership, error and learning culture and team development. In addition, selected practical examples from the German and international healthcare sectors were analyzed. The review also incorporated studies on the effectiveness of (simulation) training and incident reporting and learning systems.</p><p><strong>Results: </strong>The introduction of a Just Culture promotes a climate of trust, fairness and continuous learning in the workplace. It facilitates open communication about adverse events, supports systematic root cause analysis and reduces individual blame. Staff report increased psychological safety, reduced work-related stress and higher job satisfaction. Modern leadership approaches, such as transformational, shared and humble leadership, can further enhance teamwork and care quality. Evidence also suggests positive effects on employee retention and organizational performance, although causal relationships remain underexplored.</p><p><strong>Discussion: </strong>An organizational culture shaped by Just Culture principles constitutes a key success factor for healthcare institutions. It fosters psychological safety, strengthens a sense of responsibility and enables collective learning; however, successful implementation requires a targeted evolution of leadership structures, continuous training and the development of supportive frameworks, such as reporting systems and interprofessional reflection formats. When effectively implemented, Just Culture can help secure care quality, retain skilled professionals and create a strategic advantage in an increasingly complex and economically pressured healthcare environment.</p>","PeriodicalId":72805,"journal":{"name":"Die Anaesthesiologie","volume":" ","pages":"801-810"},"PeriodicalIF":1.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145454184","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Just culture as a chance for the future for hospitals]. (文化是医院未来的一个机会)。
IF 1 Pub Date : 2025-12-01 Epub Date: 2025-11-20 DOI: 10.1007/s00101-025-01614-6
Volker Wenzel, S Heimgärtner
{"title":"[Just culture as a chance for the future for hospitals].","authors":"Volker Wenzel, S Heimgärtner","doi":"10.1007/s00101-025-01614-6","DOIUrl":"10.1007/s00101-025-01614-6","url":null,"abstract":"","PeriodicalId":72805,"journal":{"name":"Die Anaesthesiologie","volume":" ","pages":"797-800"},"PeriodicalIF":1.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145566211","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Resuscitative endovascular balloon occlusion of the aorta-REBOA for bleeding control in the prehospital context : Overview of available cases and evaluation of the evidence]. [院前复苏血管内球囊阻断主动脉- reboa的出血控制:现有病例综述和证据评价]。
IF 1 Pub Date : 2025-12-01 Epub Date: 2025-10-29 DOI: 10.1007/s00101-025-01608-4
Peter Hilbert-Carius, H Wrigge, F Streibert, M Lautenschläger, A Großstück

Background: Noncompressible torso hemorrhage (NCTH) poses a considerable problem in prehospital care as bleeding control is not possible in this situation. Resuscitative endovascular balloon occlusion of the aorta (REBOA) is a minimally invasive endovascular procedure that could be an option for temporary bleeding control or reduction. The aim of this study was to review and classify the available literature on the prehospital use of REBOA in the context of traumatic hemorrhagic shock.

Methods: A literature search was carried out in various databases (PubMed, Embase, Web of Sciences, Google Scholar) using the search terms "prehospital and REBOA" or "prehospital and resuscitative endovascular balloon occlusion of the aorta" to identify relevant studies. Only studies, case series or case reports of prehospital REBOA use were included in the review.

Results: A total of 15 studies (7 case reports, 8 case series) with a total of 80 patients (45 male, 15 female, 20 without gender information) with a mean age of 41.4 years (range 16-75 years) who underwent prehospital REBOA for hemorrhage control were included in the review and analyzed. Of these, 34 patients were treated in a military context and 46 patients in a civilian context. The average Injury Severity Score (ISS) was 41.4 (min. 9/max. 75) points. The use of REBOA was feasible in the prehospital setting with an overall success rate of > 85% ranging from 72% to 100%. The prehospital application leads to a hemodynamic stabilization with a mean systolic blood pressure increase of 50 mm Hg. Of the treated patients 89% could be transported alive to hospital and 45% survived to hospital discharge. Complications were reported in 29%, not all of which were specific to REBOA. Publication bias must be considered and therefore the results have to be interpreted with caution.

Conclusion: The application of REBOA in the prehospital setting in the context of traumatic hemorrhagic shock is feasible with a high success rate. The majority of patients can be hospitalized but only slightly less than 50% survive to hospital discharge. The currently available evidence relates exclusively to case reports and case series and is therefore still weak. A not insignificant publication bias must be considered.

背景:不可压缩性躯干出血(NCTH)在院前护理中提出了相当大的问题,因为在这种情况下出血控制是不可能的。复苏血管内球囊阻断主动脉(REBOA)是一种微创血管内手术,可以暂时控制或减少出血。本研究的目的是回顾和分类有关院前使用REBOA在外伤性失血性休克的背景下的现有文献。方法:以“院前和REBOA”或“院前和复苏性血管内球囊阻塞主动脉”为检索词,在PubMed、Embase、Web of Sciences、谷歌Scholar等数据库中进行文献检索,查找相关研究。只有院前REBOA使用的研究、病例系列或病例报告被纳入本综述。结果:共纳入15项研究(7例报告,8例系列),共80例患者(男45例,女15例,无性别信息20例),平均年龄41.4岁(16-75岁),行院前REBOA止血。其中34名患者在军事环境中接受治疗,46名患者在平民环境中接受治疗。平均损伤严重程度评分(ISS)为41.4分。9 / max。75)点。REBOA在院前使用是可行的,总体成功率为> 85%,范围为72%至100%。院前应用导致血流动力学稳定,平均收缩压升高50 mm Hg。在接受治疗的患者中,89%可以活着送往医院,45%存活至出院。并发症发生率为29%,并非所有并发症都是REBOA特有的。必须考虑发表偏倚,因此必须谨慎解释结果。结论:REBOA在外伤性失血性休克院前应用是可行的,成功率高。大多数患者可以住院治疗,但只有略低于50%的患者能存活到出院。目前可获得的证据仅涉及病例报告和病例系列,因此仍然薄弱。发表偏倚必须考虑。
{"title":"[Resuscitative endovascular balloon occlusion of the aorta-REBOA for bleeding control in the prehospital context : Overview of available cases and evaluation of the evidence].","authors":"Peter Hilbert-Carius, H Wrigge, F Streibert, M Lautenschläger, A Großstück","doi":"10.1007/s00101-025-01608-4","DOIUrl":"10.1007/s00101-025-01608-4","url":null,"abstract":"<p><strong>Background: </strong>Noncompressible torso hemorrhage (NCTH) poses a considerable problem in prehospital care as bleeding control is not possible in this situation. Resuscitative endovascular balloon occlusion of the aorta (REBOA) is a minimally invasive endovascular procedure that could be an option for temporary bleeding control or reduction. The aim of this study was to review and classify the available literature on the prehospital use of REBOA in the context of traumatic hemorrhagic shock.</p><p><strong>Methods: </strong>A literature search was carried out in various databases (PubMed, Embase, Web of Sciences, Google Scholar) using the search terms \"prehospital and REBOA\" or \"prehospital and resuscitative endovascular balloon occlusion of the aorta\" to identify relevant studies. Only studies, case series or case reports of prehospital REBOA use were included in the review.</p><p><strong>Results: </strong>A total of 15 studies (7 case reports, 8 case series) with a total of 80 patients (45 male, 15 female, 20 without gender information) with a mean age of 41.4 years (range 16-75 years) who underwent prehospital REBOA for hemorrhage control were included in the review and analyzed. Of these, 34 patients were treated in a military context and 46 patients in a civilian context. The average Injury Severity Score (ISS) was 41.4 (min. 9/max. 75) points. The use of REBOA was feasible in the prehospital setting with an overall success rate of > 85% ranging from 72% to 100%. The prehospital application leads to a hemodynamic stabilization with a mean systolic blood pressure increase of 50 mm Hg. Of the treated patients 89% could be transported alive to hospital and 45% survived to hospital discharge. Complications were reported in 29%, not all of which were specific to REBOA. Publication bias must be considered and therefore the results have to be interpreted with caution.</p><p><strong>Conclusion: </strong>The application of REBOA in the prehospital setting in the context of traumatic hemorrhagic shock is feasible with a high success rate. The majority of patients can be hospitalized but only slightly less than 50% survive to hospital discharge. The currently available evidence relates exclusively to case reports and case series and is therefore still weak. A not insignificant publication bias must be considered.</p>","PeriodicalId":72805,"journal":{"name":"Die Anaesthesiologie","volume":" ","pages":"843-849"},"PeriodicalIF":1.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145403025","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Evidence-based and practical: scrutiny of the new guidelines on platelet transfusion]. [循证实用:血小板输注新指南的审查]。
IF 1 Pub Date : 2025-12-01 Epub Date: 2025-11-03 DOI: 10.1007/s00101-025-01603-9
Philipp Pütz, Mark Coburn, Florian Piekarski

The transfusion of platelet concentrates is an established treatment for thrombocytopenia or platelet dysfunction. The new international guideline from the Association for the Advancement of Blood and Biotherapies in collaboration with the International Collaboration for Transfusion Medicine Guidelines is based on 21 randomized and 13 observational studies comparing restrictive and liberal transfusion strategies. The evidence shows that restrictive strategies do not significantly increase 30-day mortality or the risk of severe bleeding (WHO grade 3-4), but are associated with a lower rate of transfusion-associated adverse events, improved resource availability, and lower costs. The guideline supports restrictive transfusion strategies, but emphasizes the need for individual clinical decisions taking into account symptoms, comorbidities, and patient preferences.

输注浓缩血小板是治疗血小板减少症或血小板功能障碍的常用方法。血液和生物治疗促进协会与国际输血医学指南合作制定的新的国际指南是基于比较限制性和自由输血策略的21项随机研究和13项观察性研究。有证据表明,限制性策略不会显著增加30天死亡率或严重出血风险(世卫组织3-4级),但与较低的输血相关不良事件发生率、改善的资源可用性和较低的成本相关。该指南支持限制性输血策略,但强调需要考虑到症状、合并症和患者偏好的个体临床决策。
{"title":"[Evidence-based and practical: scrutiny of the new guidelines on platelet transfusion].","authors":"Philipp Pütz, Mark Coburn, Florian Piekarski","doi":"10.1007/s00101-025-01603-9","DOIUrl":"10.1007/s00101-025-01603-9","url":null,"abstract":"<p><p>The transfusion of platelet concentrates is an established treatment for thrombocytopenia or platelet dysfunction. The new international guideline from the Association for the Advancement of Blood and Biotherapies in collaboration with the International Collaboration for Transfusion Medicine Guidelines is based on 21 randomized and 13 observational studies comparing restrictive and liberal transfusion strategies. The evidence shows that restrictive strategies do not significantly increase 30-day mortality or the risk of severe bleeding (WHO grade 3-4), but are associated with a lower rate of transfusion-associated adverse events, improved resource availability, and lower costs. The guideline supports restrictive transfusion strategies, but emphasizes the need for individual clinical decisions taking into account symptoms, comorbidities, and patient preferences.</p>","PeriodicalId":72805,"journal":{"name":"Die Anaesthesiologie","volume":" ","pages":"839-842"},"PeriodicalIF":1.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12660358/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145439258","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Perioperative management of anesthesia in heart failure]. 心衰患者麻醉的围手术期处理。
IF 1 Pub Date : 2025-12-01 Epub Date: 2025-11-19 DOI: 10.1007/s00101-025-01607-5
Carla Klapproth, Martin Bender, Tobias Ninke, Tobias Wöhrle, Erich Kilger

Heart failure is a significant risk factor for perioperative complications and postoperative mortality. A detailed medical history and physical examination during the preoperative consultation should guide decisions regarding further measures, such as the assessment of cardiac biomarkers, iron supplementation or echocardiography. Particularly in acutely decompensated patients, an interdisciplinary discussion should take place regarding the possibility of compensating the condition before an elective procedure. Preoperative cardiac medication should be adjusted or paused as needed. Adequate monitoring should enable a differentiated anesthesia induction, anesthesia management and postoperative monitoring to improve patient outcome. Intraoperative anesthesia management should include maintaining normotensive blood pressure, volume management, and a differentiated catecholamine treatment.

心衰是围手术期并发症和术后死亡率的重要危险因素。术前咨询时详细的病史和体格检查应指导进一步措施的决定,如心脏生物标志物评估、铁补充或超声心动图。特别是在急性失代偿的患者中,在选择手术前,应该进行跨学科的讨论,讨论补偿病情的可能性。术前心脏用药应根据需要调整或暂停。充分的监测应能够区分麻醉诱导、麻醉管理和术后监测,以改善患者预后。术中麻醉管理应包括维持正常血压、容量管理和差异化儿茶酚胺治疗。
{"title":"[Perioperative management of anesthesia in heart failure].","authors":"Carla Klapproth, Martin Bender, Tobias Ninke, Tobias Wöhrle, Erich Kilger","doi":"10.1007/s00101-025-01607-5","DOIUrl":"10.1007/s00101-025-01607-5","url":null,"abstract":"<p><p>Heart failure is a significant risk factor for perioperative complications and postoperative mortality. A detailed medical history and physical examination during the preoperative consultation should guide decisions regarding further measures, such as the assessment of cardiac biomarkers, iron supplementation or echocardiography. Particularly in acutely decompensated patients, an interdisciplinary discussion should take place regarding the possibility of compensating the condition before an elective procedure. Preoperative cardiac medication should be adjusted or paused as needed. Adequate monitoring should enable a differentiated anesthesia induction, anesthesia management and postoperative monitoring to improve patient outcome. Intraoperative anesthesia management should include maintaining normotensive blood pressure, volume management, and a differentiated catecholamine treatment.</p>","PeriodicalId":72805,"journal":{"name":"Die Anaesthesiologie","volume":" ","pages":"850-860"},"PeriodicalIF":1.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145551973","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[First come, first failed : The rise and fall of Germany's Triage law]. [先到先败:德国检伤分类法的兴衰]。
IF 1 Pub Date : 2025-12-01 Epub Date: 2025-11-27 DOI: 10.1007/s00101-025-01616-4
Bernhard Zwißler, Axel R Heller, Gunnar Duttge, Andrej Michalsen
{"title":"[First come, first failed : The rise and fall of Germany's Triage law].","authors":"Bernhard Zwißler, Axel R Heller, Gunnar Duttge, Andrej Michalsen","doi":"10.1007/s00101-025-01616-4","DOIUrl":"https://doi.org/10.1007/s00101-025-01616-4","url":null,"abstract":"","PeriodicalId":72805,"journal":{"name":"Die Anaesthesiologie","volume":"74 12","pages":"793-796"},"PeriodicalIF":1.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145643625","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Postoperative hyponatremic seizure induced by urinary retention following total knee arthroplasty with an enhanced recovery after surgery protocol : Case report and literature review. 全膝关节置换术后尿潴留引起的低钠血症发作,术后恢复增强:病例报告和文献回顾。
IF 1 Pub Date : 2025-11-06 DOI: 10.1007/s00101-025-01606-6
Hsin-Hsin Lee, Yuan-Hsin Tsai
{"title":"Postoperative hyponatremic seizure induced by urinary retention following total knee arthroplasty with an enhanced recovery after surgery protocol : Case report and literature review.","authors":"Hsin-Hsin Lee, Yuan-Hsin Tsai","doi":"10.1007/s00101-025-01606-6","DOIUrl":"https://doi.org/10.1007/s00101-025-01606-6","url":null,"abstract":"","PeriodicalId":72805,"journal":{"name":"Die Anaesthesiologie","volume":" ","pages":""},"PeriodicalIF":1.0,"publicationDate":"2025-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145454158","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Die Anaesthesiologie
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1